Processing, please wait...
4 lectures / chairs 2 videos 1 badge
100 videos

Dr Carlos Gustavo WAMBIER

Dermatologist
United States

Dr Wambier is an Associate Professor of Dermatology, Clinician Educator at the Warren Alpert Medical School of Brown University.

Dr Wambier is the Director of the Center for Lasers and Aesthetics of Brown Dermatology, Attending Dermatologist at the Brown Dermatology's Hair Clinic and Resident Cosmetic Clinic, and the Medical Director of Dermatology Clinical Trials and the Dermatologist of the Rhode Island Burn Center at the Rhode Island Hospital.Dr Wambier has given over 100 lectures in national and international dermatology meetings, and over 150 peer-reviewed articles published.

 


Background:

University of Sao Paulo, Brazil: Medical Doctor degree (2004), medical residency in Dermatology (2009), and Science Doctorate degree in Dermatology (PhD, 2012). Yale University, USA: Post-doctorate (2018-2020).

 


Dr Wambier is recognized worldwide as an expert in the field of procedural dermatology, with expertise in injectables (fillers, neurotoxins, and lipolysis), lasers, and drug-delivery procedures for both medical and cosmetic indications (such as scars and hair growth). Dr Wambier is internationally acclaimed as a leader in chemical peels, with numerous publications on the subject including the cover of the Journal of the American Academy of Dermatology of August 2019, which featured two CME articles about chemical peels which he was the leading author. His innovations in techniques and research in the field of chemical peels have triggered a renewed interest on phenol-croton oil peels (also known as advanced, or deep peels) in the dermatologic academia.

 


He became an expert in hair growth, wound healing, inflammation, drug eruptions, photodynamic therapy, and leprosy during his years of research at Ribeirão Preto Medical School. After that period, he focused in Chemical Peeling research when he became a Tenure-track Associate Professor of Dermatology at the State University of Ponta Grossa 2013-18. Since 2018 Dr Wambier was been an investigator of novel JAK inhibitors in dermatology.

read more
add item add Carlos Gustavo WAMBIER

Carlos Gustavo WAMBIER's publications (50)

Commentary on picosecond Nd:YAG laser therapy for pigmentation due to lichen planus pigmentosus in a patient with skin of color.

May, 2024

read more

JAAD case reports

Comparative Long-Term Efficacy of Phenol-Croton Oil Chemical Peels for Persistent Melasma at Varied Croton tiglium Oil Concentrations.

Apr, 2024

read more

Journal of the American Academy of Dermatology

Minoxidil sulfotransferase enzymatical activity in plants: A novel paradigm in increasing minoxidil response in androgenetic alopecia.

Jan, 2024

Minoxidil is the only US FDA approved topical drug for the treatment of androgenetic alopecia (AGA). Minoxidil is effective in hair re-growth in 30%-40% of patients and 50% of males. To exert its hair growing effect, minoxidil must be sulfonated in the scalp by the minoxidil sulfotransferase enzyme (SULT1A1). Low scalp SULT1A1 correlates with lack of minoxidil response; thus, supplementing the scalp SULT1A1 with naturally occurring minoxidil sulfotransferase enzymes could potentially improve treatment outcomes in AGA patients. read more

Journal of cosmetic dermatology
Load more  

Carlos Gustavo WAMBIER's scientific societies (4)